No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunder, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 276 contracts
Samples: Sales Agreement (Sagimet Biosciences Inc.), Sales Agreement (Poseida Therapeutics, Inc.), Sales Agreement (Semler Scientific, Inc.)
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunderhereunder pursuant to Section 23, neither of the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act405), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 89 contracts
Samples: Financing Agreement (Luminar Technologies, Inc./De), Common Stock (Nanoviricides, Inc.), Sales Agreement (Cumberland Pharmaceuticals Inc)
No Offer to Sell. Other than an Issuer Free Writing Prospectus a free writing prospectus (as defined in Rule 405 under the Securities Act) approved in advance by the Company and the Agent in its capacity as agent hereunderAgent, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as suchagent) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 67 contracts
Samples: Sales Agreement (Zura Bio LTD), Sales Agreement (AEON Biopharma, Inc.), Sales Agreement (InflaRx N.V.)
No Offer to Sell. Other than the Prospectus and an Issuer Free Writing Prospectus approved in advance by the Company and the Sales Agent in its capacity as principal or agent hereunder, neither the Sales Agent nor the Company (including its agents and representatives, other than the Sales Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 63 contracts
Samples: Sales Agreement (GeoVax Labs, Inc.), Sales Agreement (ZyVersa Therapeutics, Inc.), Sales Agreement (Aqua Metals, Inc.)
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunder, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its their capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 36 contracts
Samples: Sales Agreement (PLBY Group, Inc.), Sales Agreement (Sonim Technologies Inc), Sales Agreement (Astra Space, Inc.)
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent Agents in its their capacity as agent agents hereunder, neither the Agent Agents nor the Company (including its agents and representatives, other than the Agent Agents in its their capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 32 contracts
Samples: Sales Agreement (Cipher Mining Inc.), Sales Agreement (Perspective Therapeutics, Inc.), Sales Agreement (Crinetics Pharmaceuticals, Inc.)
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent Agents in its their capacity as agent hereunderagents hereunder pursuant to Section 23, neither of the Agent Agents nor the Company (including its agents and representatives, other than the Agent Agents in its their capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act405), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 17 contracts
Samples: Sales Agreement (Sunworks, Inc.), Common Stock (Sunworks, Inc.), Sales Agreement (Terawulf Inc.)
No Offer to Sell. Other than an the Prospectus and the Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunder, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 15 contracts
Samples: Equity Distribution Agreement (Inspirato Inc), Lexaria Bioscience Corp., NeuroSense Therapeutics Ltd.
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunderProspectus, neither the Sales Agent nor the Company (including its agents and representatives, other than the Sales Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 15 contracts
Samples: Common Stock Sales Agreement (Akerna Corp.), Equity Distribution Agreement (Ondas Holdings Inc.), Equity Distribution Agreement (Frequency Therapeutics, Inc.)
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent Agents in its their capacity as agent hereunderagents hereunder pursuant to Section 23, neither the Agent Agents nor the Company (including its agents and representatives, other than the Agent Agents in its their capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act405), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 14 contracts
Samples: Sales Agreement (PDS Biotechnology Corp), Distribution Agreement (Biora Therapeutics, Inc.), Sales Agreement (Applied Digital Corp.)
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunder, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as such) will make, use, prepare, authorize, approve approve, or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the CommissionSEC, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 12 contracts
Samples: Common Stock (Aclarion, Inc.), Common Stock (Oragenics Inc), Sales Agreement (Singing Machine Co Inc)
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunderhereunder pursuant to Section 23, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act405), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 10 contracts
Samples: Market Issuance Sales Agreement (Neonode Inc.), Applied Digital Corp., S&W Seed Co
No Offer to Sell. Other than an a Permitted Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunderProspectus, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 10 contracts
Samples: Sales Agreement (Durect Corp), Array Biopharma (Array Biopharma Inc), Array Biopharma (Array Biopharma Inc)
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunderhereunder pursuant to Section 24, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its their capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act405), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 8 contracts
Samples: Great Ajax Corp., Great Ajax Corp., Great Ajax Corp.
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent Agents in its their capacity as agent agents hereunder, neither of the Agent Agents nor the Company (including its agents and representatives, other than the Agent Agents in its their capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 8 contracts
Samples: Sales Agreement (CONTRAFECT Corp), Sales Agreement (Stoke Therapeutics, Inc.), Ocugen, Inc.
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its their capacity as agent hereunderhereunder pursuant to Section 23, neither of the Agent nor the Company (including its agents and representatives, other than the Agent in its their capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act405), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 7 contracts
Samples: Ra Medical Systems, Inc., Forte Biosciences, Inc., NeuroMetrix, Inc.
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent Agents in its their capacity as agent hereunder, neither the Agent Agents nor the Company (including its agents and representatives, other than the Agent Agents in its their capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 7 contracts
Samples: Sales Agreement (Galmed Pharmaceuticals Ltd.), Sales Agreement (Galmed Pharmaceuticals Ltd.), Sales Agreement (CareCloud, Inc.)
No Offer to Sell. Other than an Issuer Free Writing Prospectus a free writing prospectus (as defined in Rule 405 under the Securities Act) approved in advance by the Company and the Agent in its capacity as agent hereunderAgent, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as suchagent) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 7 contracts
Samples: Sales Agreement (Axsome Therapeutics, Inc.), Sales Agreement (Axsome Therapeutics, Inc.), Sales Agreement (Axsome Therapeutics, Inc.)
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunder, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 7 contracts
Samples: Sales Agreement (Sucampo Pharmaceuticals, Inc.), Sales Agreement (Unilife Corp), Sales Agreement (Biotime Inc)
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent Ascendiant in its capacity as agent hereunder, neither the Agent Ascendiant nor the Company (including its agents and representatives, other than the Agent Ascendiant in its capacity as such) will make, use, prepare, authorize, approve approve, or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the CommissionSEC, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 7 contracts
Samples: Common Stock (Ault Alliance, Inc.), Common Stock (Ault Global Holdings, Inc.), Common Stock (DPW Holdings, Inc.)
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent Agents in its their capacity as agent agents hereunder, neither none of the Agent Agents nor the Company (including its agents and representatives, other than the Agent Agents in its their capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 6 contracts
Samples: Sales Agreement (Energy Fuels Inc), Sales Agreement (Energy Fuels Inc), Sales Agreement (Energy Fuels Inc)
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunder, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 6 contracts
Samples: Galena Biopharma (Galena Biopharma, Inc.), Sales Agreement (Chelsea Therapeutics International, Ltd.), Galena Biopharma, Inc.
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunderhereunder pursuant to Section 23, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its their capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act405), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 6 contracts
Samples: Sonoma Pharmaceuticals, Inc., Medicinova Inc, EyePoint Pharmaceuticals, Inc.
No Offer to Sell. Other Unless required by law, other than an Issuer Free Writing Prospectus a free writing prospectus (as defined in Rule 405 under the Act) approved in advance by the Company and the Agent (whose approval shall not be unreasonably withheld) in its capacity as principal or agent hereunder, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 5 contracts
Samples: Sales Agreement (AGNC Investment Corp.), Sales Agreement (MTGE Investment Corp.), Sales Agreement (MTGE Investment Corp.)
No Offer to Sell. Other than an Issuer Free Writing Prospectus a free writing prospectus (as defined in Rule 405 under the Securities Act) approved in advance in writing by the Company and the Agent in its capacity as principal or agent hereunder, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as such) will will, directly or indirectly, make, use, prepare, authorize, approve or refer to any written communication (free writing prospectus relating to the Shares to be sold by the Agent as defined in Rule 405 under principal or agent hereunder unless such free writing prospectus is used by the Securities Act), Agent and is not required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 5 contracts
Samples: Sales Agreement (Tier Reit Inc), Sales Agreement (Tier Reit Inc), Sales Agreement (Global Medical REIT Inc.)
No Offer to Sell. Other than an Issuer Free Writing Prospectus a free writing prospectus (as defined in Rule 405 under the Act) approved in advance by the Company Corporation and the Agent Agents in its capacity each of their capacities as principal or agent hereunder, neither the Agent Agents nor the Company Corporation (including its agents and representatives, other than the Agent Agents in its capacity each of their capacities as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed by it with the CommissionSEC, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 5 contracts
Samples: Distribution Agreement (Fortis Inc.), Equity Distribution Agreement (Organigram Holdings Inc.), Equity Distribution Agreement (Organigram Holdings Inc.)
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunderhereunder pursuant to Section 23, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its their capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act405), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 4 contracts
Samples: Physicians Realty Trust, Physicians Realty Trust, Physicians Realty Trust
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunder, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its their capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 4 contracts
Samples: Acasti Pharma Inc., Adcare Health Systems, Inc, Adcare Health Systems, Inc
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent Agents in its their capacity as agent agents hereunder, neither the Agent Agents nor the Company (including its agents and representatives, other than the Agent Agents in its their capacity as such) will make, use, prepare, authorize, approve approve, or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the CommissionSEC, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 4 contracts
Samples: Sales Agreement (ENDRA Life Sciences Inc.), ENDRA Life Sciences Inc., ENDRA Life Sciences Inc.
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company Manager, on behalf of the Trust, and the Agent in its capacity as agent hereunder, neither the Agent nor the Company Manager, on behalf of the Trust (including its agents and representatives, other than the Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares Units hereunder.
Appears in 4 contracts
Samples: Sales Agreement (Sprott Physical Gold & Silver Trust), Sales Agreement (Sprott Physical Silver Trust), Sales Agreement (Sprott Physical Platinum & Palladium Trust)
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunder, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its their capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 4 contracts
Samples: Sales Agreement (Innovative Solutions & Support Inc), Sales Agreement (Momentus Inc.), Sales Agreement (SITIME Corp)
No Offer to Sell. Other than an Issuer Free Writing Prospectus a free writing prospectus (as defined in Rule 405 under the Securities Act) approved in advance by the Company and the Agent in its capacity as agent hereunderAgents, neither the Agent Agents nor the Company (including its agents and representatives, other than the Agent Agents in its their capacity as suchagents) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 4 contracts
Samples: Sales Agreement (Applied Molecular Transport Inc.), Sales Agreement (Chinook Therapeutics, Inc.), Sales Agreement (89bio, Inc.)
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent Agents in its their capacity as agent hereunderagents hereunder pursuant to Section 24, neither of the Agent Agents nor the Company (including its agents and representatives, other than the Agent Agents in its their capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act405), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 4 contracts
Samples: Bitdeer Technologies Group, Iris Energy LTD, Fusion Fuel Green PLC
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunderhereunder pursuant to Section 23, neither of the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act405), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares Securities hereunder.
Appears in 4 contracts
Samples: Atlanticus Holdings Corp, Atlanticus Holdings Corp, Synchronoss Technologies Inc
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as the agent hereunderhereunder pursuant to Section 23, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act405), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 4 contracts
Samples: Moleculin Biotech, Inc., Moleculin Biotech, Inc., Brickell Biotech, Inc.
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunderor principal hereunder pursuant to Section 23, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its their capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act405), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 4 contracts
Samples: Sachem Capital Corp., Sachem Capital Corp., Cherry Hill Mortgage Investment Corp
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunderhereunder pursuant to Section 23, neither of the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 4 contracts
Samples: Trinity Place Holdings Inc., Orion Energy Systems, Inc., Teligent, Inc.
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company Partnership and the Agent in its capacity as agent hereunderhereunder pursuant to Section 22, neither the Agent nor the Company Partnership (including its agents and representatives, other than the Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act405), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares Units hereunder.
Appears in 4 contracts
Samples: Sales Agreement (Hoegh LNG Partners LP), KNOT Offshore Partners LP, KNOT Offshore Partners LP
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunder, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its their capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 4 contracts
Samples: IDI, Inc., Ascent Solar Technologies, Inc., Uqm Technologies Inc
No Offer to Sell. Other than an Issuer Free Writing Prospectus Prospectuses approved in advance by the Company and the Agent in its capacity as agent hereunder, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 3 contracts
Samples: Sales Agreement (Aurinia Pharmaceuticals Inc.), Aptose Biosciences Inc., Aurinia Pharmaceuticals Inc.
No Offer to Sell. Other than an the Prospectus and the Issuer Free Writing Prospectus approved in advance by the Company and the Agent Agents in its their capacity as agent agents hereunder, neither the Agent Agents nor the Company (including its agents and representatives, other than the Agent Agents in its their capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 3 contracts
Samples: Aileron Therapeutics Inc, Actinium Pharmaceuticals, Inc., CNS Pharmaceuticals, Inc.
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunderhereunder (such approval not to be unreasonably withheld, conditioned or delayed), neither the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act405), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 3 contracts
Samples: Ocular Therapeutix, Inc, Ocular Therapeutix, Inc, Ocular Therapeutix, Inc
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent both Agents in its their capacity as agent hereunder, neither of the Agent Agents nor the Company (including its agents and representatives, other than the Agent Agents in its their capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 3 contracts
Samples: Xoma LTD /De/, YRC Worldwide Inc., ARYx Therapeutics, Inc.
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent Agents in its their capacity as agent agents hereunder, neither the Agent Agents nor the Company (including its agents and representatives, other than the Agent Agents in its their capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act405), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 3 contracts
Samples: Sales Agreement (Alx Oncology Holdings Inc), Sales Agreement (Marker Therapeutics, Inc.), Mind Medicine (MindMed) Inc.
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunder, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as such) will directly or indirectly, make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under Issuer Free Writing Prospectus relating to the Securities Act), required Placement Shares to be filed with sold by the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares Agent as agent hereunder.
Appears in 3 contracts
Samples: Novavax Inc, Novavax Inc, Novavax Inc
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company Manager, on behalf of the Trust, and the Agent Agents in its their capacity as agent agents hereunder, neither the Agent Agents nor the Company Manager, on behalf of the Trust (including its agents and representatives, other than the Agent Agents in its their capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares Units hereunder.
Appears in 3 contracts
Samples: Sales Agreement (Sprott Physical Silver Trust), Sales Agreement (Sprott Physical Gold Trust), Sales Agreement (Sprott Physical Platinum & Palladium Trust)
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent Agents in its their capacity as agent agents hereunder, neither the Agent Agents nor the Company (including its agents and representatives, other than the Agent Agents in its their capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares ADSs hereunder.
Appears in 3 contracts
Samples: Sales Agreement (Gracell Biotechnologies Inc.), Sales Agreement (BICYCLE THERAPEUTICS PLC), Genenta Science S.p.A.
No Offer to Sell. Other than an Issuer Free Writing Prospectus a free writing prospectus (as defined in Rule 405 under the Securities Act) approved in advance by the Company and the Agent in its capacity as agent hereunderAgent, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as suchagent) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares ADSs hereunder.
Appears in 3 contracts
Samples: Sales Agreement (Adagene Inc.), Sales Agreement (Itamar Medical Ltd.), Sales Agreement (RedHill Biopharma Ltd.)
No Offer to Sell. Other than an the Prospectus and any Issuer Free Writing Prospectus approved in advance by the Company Partnership and the Agent in its capacity as agent hereunder, neither the Agent nor the Company Partnership (including its agents and representatives, other than the Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares Units hereunder.
Appears in 3 contracts
Samples: America First Multifamily Investors, L.P., America First Multifamily Investors, L.P., America First Multifamily Investors, L.P.
No Offer to Sell. Other than the Prospectus and an Issuer Free Writing Prospectus approved in advance by the Company and the Agent Sales Agents in its their capacity as agent principals or agents hereunder, neither none of the Agent nor Sales Agents or the Company (including its agents and representatives, other than the Agent Sales Agents in its their capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 3 contracts
Samples: Sales Agreement (Scilex Holding Co), Sales Agreement (Scilex Holding Co), Sales Agreement (Sorrento Therapeutics, Inc.)
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company Partnership and the Agent Agents in its their capacity as agent hereunderhereunder pursuant to Section 23, neither the Agent Agents nor the Company Partnership (including its agents and representatives, other than the Agent Agents in its their capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act405), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares Units hereunder.
Appears in 3 contracts
Samples: Security Agreement (Landmark Infrastructure Partners LP), Landmark Infrastructure Partners LP, Stonemor Partners Lp
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunder, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act405), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 3 contracts
Samples: Sales Agreement (Eton Pharmaceuticals, Inc.), Sales Agreement (Pliant Therapeutics, Inc.), TherapeuticsMD, Inc.
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunderhereunder pursuant to Section 23, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as such) will not make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act405), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 2 contracts
Samples: Entera Bio Ltd., Entera Bio Ltd.
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent Xxxxxxxxxx in its capacity as agent hereunder, neither the Agent Xxxxxxxxxx nor the Company (including its agents and representatives, other than the Agent Xxxxxxxxxx in its their capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 2 contracts
Samples: Market Issuance Sales Agreement (Aeterna Zentaris Inc.), Market Issuance Sales Agreement (Aeterna Zentaris Inc.)
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunder, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares ADSs hereunder.
Appears in 2 contracts
Samples: Deposit Agreement (Safe-T Group Ltd.), Genenta Science S.p.A.
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunder, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its their capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder..
Appears in 2 contracts
Samples: Sales Agreement (Cassava Sciences Inc), Pain Therapeutics Inc
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunder, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities ActAct Regulations), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 2 contracts
Samples: Surface Oncology, Inc., Surface Oncology, Inc.
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunder, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares Securities hereunder.
Appears in 2 contracts
Samples: Deposit Agreement (Bionomics Limited/Fi), Deposit Agreement (Bionomics Limited/Fi)
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent Agents in its their capacity as agent hereunderAgents hereunder pursuant to Section 23, neither of the Agent Agents nor the Company (including its agents and representatives, other than the Agent Agents in its their capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 2 contracts
Samples: Centrus Energy Corp, Centrus Energy Corp
No Offer to Sell. Other than an Issuer a Permitted Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunderProspectus, neither the an Agent nor the Company (including its agents and representatives, other than the Agent Agents in its their capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Common Stock relating to the Placement Shares to be sold by an Agent as principal or agent hereunder.
Appears in 2 contracts
Samples: Sales Agreement (Aspen Aerogels Inc), Sales Agreement (Aspen Aerogels Inc)
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent Agents in its their capacity as agent hereunder, neither the Agent Agents nor the Company (including its agents and representatives, other than any of the Agent Agents in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 2 contracts
Samples: Sales Agreement (Avino Silver & Gold Mines LTD), Sales Agreement (Avino Silver & Gold Mines LTD)
No Offer to Sell. Other than an Issuer Free Writing Prospectus a free writing prospectus (as defined in Rule 405 under the Act) approved in advance by the Company and the Agent Agents in its their capacity as agent principal or agents hereunder, neither the Agent Agents nor the Company (including its agents and representatives, other than the Agent Agents in its their capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 2 contracts
Samples: Sales Agreement (Curis Inc), Curis Inc
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent Agents in its their capacity as agent agents hereunder, neither the Agent Agents nor the Company (including its agents and representatives, other than the Agent Agents in its their capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 2 contracts
Samples: Sales Agreement (Hyzon Motors Inc.), Sales Agreement (Ampio Pharmaceuticals, Inc.)
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent Agents in its their capacity as agent hereunderagents hereunder pursuant to Sxxxxxx 00, neither xxxx of the Agent Agents nor the Company (including its agents and representatives, other than the Agent Agents in its their capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act405), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 2 contracts
No Offer to Sell. Other than an the Prospectus and any Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunder, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 2 contracts
Samples: Monopar Therapeutics, Monopar Therapeutics
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent Agents in its their capacity as agent agents hereunder, neither the Agent Agents nor the Company (including its agents and representatives, other than the Agent Agents in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 2 contracts
Samples: Sales Agreement (RAPT Therapeutics, Inc.), RAPT Therapeutics, Inc.
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent Agents in its their capacity as agent hereunderagents hereunder pursuant to Section 23, neither the Agent Agents nor the Company (including its agents and representatives, other than the Agent Agents in its their capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 2 contracts
Samples: Agency and Security Agreement (Exela Technologies, Inc.), Exela Technologies, Inc.
No Offer to Sell. Other than an a Permitted Issuer Free Writing Prospectus Prospectus, approved in advance by the Company and the Agent in its capacity as agent hereunderAgent, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 2 contracts
Samples: Sales Agreement (Verastem, Inc.), Sales Agreement (Verastem, Inc.)
No Offer to Sell. Other than an Issuer the Prospectus or a Permitted Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunderProspectus, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares Common Stock hereunder.
Appears in 2 contracts
Samples: Sales Agreement (Olema Pharmaceuticals, Inc.), Sales Agreement (Olema Pharmaceuticals, Inc.)
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunderhereunder pursuant to Section 23, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 2 contracts
Samples: Better Therapeutics, Inc., Plug Power Inc
No Offer to Sell. Other than an Issuer a Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunderhereunder (such approval not to be unreasonably withheld, conditioned or delayed), neither the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 2 contracts
Samples: Open Market Sale (Nabriva Therapeutics PLC), Nabriva Therapeutics PLC
No Offer to Sell. Other than an Issuer Free Writing Prospectus (as defined below) approved in advance by the Company and the Agent in its capacity as agent hereunderor principal hereunder pursuant to Section 23, neither the Agent nor the Company (including its agents and representatives, other than the Agent and Alternative Agent in its their capacity as such) will make, use, prepare, authorize, approve or refer to any “written communication communication” (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 2 contracts
Samples: Cherry Hill Mortgage Investment Corp, Cherry Hill Mortgage Investment Corp
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent Noble in its capacity as agent hereunder, neither the Agent Noble nor the Company (including its agents and representatives, other than the Agent Noble in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 2 contracts
Samples: Equity Distribution Agreement (Pyxis Tankers Inc.), Equity Distribution Agreement (Peregrine Pharmaceuticals Inc)
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunder, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunderunder this Agreement.
Appears in 2 contracts
Samples: Bluerock Residential Growth REIT, Inc., Bluerock Residential Growth REIT, Inc.
No Offer to Sell. Other than an Issuer Free Writing Prospectus a free writing prospectus (as defined in Rule 405 under the Securities Act) approved in advance by the Company and the Agents, each Agent in its capacity as principal or agent hereunder, neither the Agent Agents nor the Company (including its agents and representatives, other than the Agent Agents in its their capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 2 contracts
Samples: Sales Agreement (Provention Bio, Inc.), Sales Agreement (Provention Bio, Inc.)
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent Agents in its their capacity as agent hereunderAgents hereunder pursuant to Section 23, neither of the Agent Agents nor the Company (including its agents and representatives, other than the Agent Agents in its their capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act405), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 2 contracts
Samples: Pangaea Logistics Solutions Ltd., Pangaea Logistics Solutions Ltd.
No Offer to Sell. Other than an the Prospectus and the Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunder, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its their capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 2 contracts
Samples: BioPharmX Corp, ARCA Biopharma, Inc.
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunder, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares to be sold by the Agent hereunder.
Appears in 2 contracts
Samples: CymaBay Therapeutics, Inc., CymaBay Therapeutics, Inc.
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent Agents in its their capacity as agent hereunderagents hereunder (such approval by the Agent not to be unreasonably conditioned, delayed or withheld), neither the Agent Agents nor the Company (including its agents and representatives, other than the Agent Agents in its their capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 2 contracts
Samples: Adicet Bio, Inc., resTORbio, Inc.
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunderhereunder pursuant to Section 23, neither of the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act405), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares Notes hereunder.
Appears in 2 contracts
Samples: Scorpio Tankers Inc., Global Ship Lease, Inc.
No Offer to Sell. Other than an Issuer Free Writing Prospectus a free writing prospectus (as defined in Rule 405) approved in advance by the Company and the Agent in its capacity as agent hereunderAgent, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as suchagent) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act405), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 2 contracts
Samples: Sales Agreement (Arcturus Therapeutics Holdings Inc.), Sales Agreement (Arcturus Therapeutics Ltd.)
No Offer to Sell. Other than an Issuer Free Writing Prospectus a free writing prospectus (as defined in Rule 405 under the Securities Act) approved in advance by the Company and the Agent in its capacity as agent hereunderAgents, neither the Agent Agents nor the Company (including its agents and representatives, other than the Agent Agents in its their capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 2 contracts
Samples: Sales Agreement (Mirum Pharmaceuticals, Inc.), Sales Agreement (Taysha Gene Therapies, Inc.)
No Offer to Sell. Other than the Prospectus and an Issuer Free Writing Prospectus approved in advance by the Company and the Agent Sales Agents in its their capacity as principal or agent hereunder, neither the Agent Sales Agents nor the Company (including its agents and representatives, other than the Agent Sales Agents in its their capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 2 contracts
Samples: Common Stock (Cineverse Corp.), Sales Agreement (Cinedigm Corp.)
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent Agents in its their capacity as agent hereunderagents hereunder (such approval by the Agents not to be unreasonably conditioned, delayed or withheld), neither the Agent Agents nor the Company (including its their agents and representatives, other than the Agent Agents in its their capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 2 contracts
Samples: Sales Agreement (fuboTV Inc. /FL), Sales Agreement (fuboTV Inc. /FL)
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunder, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.. (r)
Appears in 2 contracts
Samples: Loan Agreement (Volta Inc.), BigBear.ai Holdings, Inc.
No Offer to Sell. Other than the Registration Statement, the Prospectus, any amendment or supplement thereto, or an Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunder, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its their capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 2 contracts
Samples: Rait Financial Trust (RAIT Financial Trust), RAIT Financial Trust
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunderhereunder pursuant to Section 23, neither of the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act405), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Common Shares or Preferred Shares hereunder.
Appears in 2 contracts
Samples: Chicken Soup for the Soul Entertainment, Inc., Chicken Soup for the Soul Entertainment, Inc.
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunderor Permitted Free Writing Prospectus, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 1 contract
No Offer to Sell. Other than an Issuer Free Writing Prospectus a free writing prospectus (as defined in Rule 405 under the Securities Act) approved in advance by the Company and the Agent in its capacity as agent hereunderAgent, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as suchagent) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.. #95784421v14
Appears in 1 contract
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunderAgent, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 1 contract
Samples: Sales Agreement (YRC Worldwide Inc.)
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunder, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under of the Securities ActAct Regulations), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 1 contract
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its their capacity as agent Agent hereunder, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its their capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 1 contract
Samples: ProPhase Labs, Inc.
No Offer to Sell. Other than the Prospectus and an Issuer Free Writing Prospectus approved in advance by the Company and the Sales Agent in its capacity as principal or agent hereunder, neither the Sales Agent nor the Company (including its agents and representatives, other than the Sales Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, Commission that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 1 contract
No Offer to Sell. Other than an Issuer Free Writing Prospectus a free writing prospectus (as defined in Rule 405 under the Act) approved in advance by the Company and the Agent in its capacity as principal or agent hereunder, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 1 contract
Samples: Curis Inc
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent Agents in its their capacity as agent hereunderagents hereunder pursuant to Xxxxxxx 00, neither xxxx of the Agent Agents nor the Company (including its agents and representatives, other than the Agent Agents in its their capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act405), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 1 contract
Samples: Meta Materials Inc.
No Offer to Sell. Other than an a Permitted Issuer Free Writing Prospectus approved in advance by the Company and the Agent in its capacity as agent hereunderAgent, neither the Agent nor the Company (including its agents and representatives, other than the Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 1 contract
Samples: Sales Agreement (Veracyte, Inc.)
No Offer to Sell. Other than the Prospectus and an Issuer Free Writing Prospectus approved in advance by the Company and the Agent Sales Agents in its capacity as principal or agent hereunder, neither the Agent Sales Agents nor the Company (including its agents and representatives, other than the Agent Sales Agents in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 1 contract
No Offer to Sell. Other than the Prospectus and an Issuer Free Writing Prospectus approved in advance by the Company and the Sales Agent in its their capacity as principal or agent hereunder, neither the Sales Agent nor the Company (including its agents and representatives, other than the Sales Agent in its their capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 1 contract
Samples: Sales Agreement (Lipocine Inc.)
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and Company, the Agent Agents in its capacity as agent hereunderhereunder pursuant to Section 23 and the Forward Purchaser, neither the Agent Agents nor the Company (including its agents and representatives, other than the Agent Agents, in its their capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act405), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 1 contract
Samples: Physicians Realty Trust
No Offer to Sell. Other than an Issuer Free Writing Prospectus approved in advance by the Company and the Agent Agents in its their capacity as agent agents hereunder, neither the Agent Agents nor the Company (including its agents and representatives, other than the Agent in its capacity as such) will make, use, prepare, authorize, approve or refer to any written communication (as defined in Rule 405 under the Securities Act), required to be filed with the Commission, that constitutes an offer to sell or solicitation of an offer to buy Placement Shares hereunder.
Appears in 1 contract